The undescended testis in children and adolescents part 2: evaluation and therapeutic approach.

Undescended testis (UDT) is defined as failure of a testis to descend into the scrotum and it is a common reason for consultation in pediatric urology. As extensively discussed in "The undescended testis in children and adolescents: part 1", the failure of a testis to descend alters testicular germ-cells development, increasing the risk of infertility and testicular cancer in adulthood. Here, we present the second part of our review and analysis of this topic with the aim to propose an updated and well-informed approach to UDT together with a treatment flow chart that may be useful to guide pediatric surgeons and urologists in the care of these patients. The main goal of the management of patients with UDT is to diminish the risk of infertility and tumor development and is based on the clinical findings at the time of diagnosis.

The undescended testis in children and adolescents. Part 1: pathophysiology, classification, and fertility- and cancer-related controversies.

Undescended testis (UDT) is defined as failure of a testis to descend into the scrotum. It is one of the most common reasons for consultation in pediatric surgery and urology with an incidence of 3% in live-born male infants. Decades ago, classical studies established that the failure of a testis to descend alters the development of its germ cells increasing the risk of infertility and testicular cancer in adulthood. More recent publications have rebutted some of the myths and raised controversies regarding the management of these patients, which, far from being limited to surgical treatment, should include pathophysiological and prognostic aspects for a comprehensive approach to the condition. Therefore, here we present an updated review divided into two parts: the first assessing the pathophysiological aspects and risks of these patients focused on fertility and cancer, and the second addressing the different treatment options for UDT.

Burnout syndrome in pediatric urology: A perspective during the COVID-19 pandemic - Ibero-American survey.

INTRODUCTION: Burnout syndrome is a major cause of decreased life quality, mental health, and productivity for physicians. It is strongly related to work overload and has been a scarcely studied topic in pediatric urology. During the COVID-19 pandemic, authorities' recommendations have led to big changes in pediatric urology practice worldwide. This study aimed to evaluate the level of burnout in Ibero-American pediatric urologists (IPUs) during this pandemic. MATERIAL AND METHODS: A cross-sectional study was conducted by applying an electronic survey during the COVID-19 pandemic peak to members of the two major associations of pediatric urology in Ibero-America (the Ibero-American Society of Pediatric Urology [SIUP] and the Brazilian School of Pediatric Urology [BSPU]) to evaluate demographic, pre-pandemic, and pandemic data. Burnout levels were assessed using the Copenhagen Burnout Inventory (CBI) questionnaire. RESULTS: A response rate of 40% was obtained (182 out of 455 IPU respondents). Participants were from 14 different countries in Ibero-America and 75.4% were male. Data showed that during the pandemic there was a significant decrease in weekly workload, that is: > 40 h per week (h/w) (91.4%-44.6%, p < 0.001); and >6 h/w (94.9%-45.1%%, p < 0.001) in operating room time (ORT). Personal (Pe-BO), work-related (W-BO), and patient-related (Pa-BO) burnout levels among IPUs were 26.3%, 22.3%, and 7.4%, respectively (Summary table). An important difference by gender was seen, with women suffering more from the syndrome (odds ratio of 2.67 [95% confidence interval, 1.285.58; p = 0.013] for Pe-BO and OR of 3.26 [95% CI, 1.52-7.01; p = 0.004] for W-BO). CONCLUSION: A significant decrease in workload for IPU during the pandemic was observed, as well as a low level of burnout syndrome during this time. However, the predominance of burnout in women found in this study is notable.

[Endoscopic treatment of vesicoureteral reflux (VUR). Comparison of various substances. Long-term results]. / Tratamiento endoscópico en reflujo vesicoureteral (RVU). Comparacion de diferentes sustancias. Resultados a largo plazo.

OBJECTIVES: The VUR is one of the most frequent pathologies in pediatric urology. Classically it has been managed with medical or surgical treatment depending on age, grade, and other variables. Over the last years, urologists have started to perform endoscopic treatment with various substances, surgery but minimally invasive. The objective of this work is to evaluate our results with this method. METHODS: Between 1996 and 2004 we performed endoscopic treatment on 41 patients (70 ureters) using different substances. We analyze VUR grade and side, improvement with one or more injections, post-operative follow-up with clinical evaluation, bladder ultrasound and voiding cystourethrogram (VCUG), and compare the long-term results of the different substances used, mainly with the evaluation of recurrences and/or urinary tract infections. RESULTS: 41 patients entered the study; collagen was injected in 13 cases, Macroplastique in 14, and Deflux in 14. Twenty-nine patients underwent bilateral injection, adding up to a total of 70 injected ureters. Collagen injection had a success rate of 53% with the first injection and 77% with the second, Macroplastique success rate was 83% with the first injection and 91% with the second, and Deflux 84% on first injection and 88% with the second. Mean post-operative follow-up was 44 months, with a range of 18-86 months. 18% of the patients presented post operative UTI, they were treatment failures. There are no UTI episodes in patients after successful treatment. CONCLUSIONS: Endoscopic treatment is a useful tool in the long-term management of VUR, both as definitive treatment or as on alternative to conventional medical management, with better results when using Macroplastique and Deflux.

Tratamiento endoscópico en reflujo vesicoureteral (RVU). Comparacion de diferentes sustancias. Resultados a largo plazo / Endoscopic treatment of vesicoureteral reflux (VRU). Comparison of various substances. Long-term results

Objetivo: El RVU es una de las patologías más frecuentes en la urología pediátrica, clásicamente se ha manejado con tratamiento médico o quirúrgico dependiendo de la edad, grado u otras variables. En los últimos años se ha comenzado a utilizar el tratamiento endoscópico, con distintas sustancias, el cual siendo quirúrgico es mínimamente invasivo. El objetivo de este trabajo es evaluar nuestros resultados con este método. Métodos: Entre 1996 y el 2004 se utilizó tratamiento endoscópico en 41 pacientes (70 uréteres) usando diferentes sustancias. Se analizó el grado y lateralidad del RVU, mejoría con 1 o más inyecciones, control post operatorio con clínica, ecografía renal vesical y uretrocistografía, y se compararon los resultados con las distintas sustancias usadas a largo plazo, evaluando principalmente las recidivas y/o cuadros de infección urinaria. Resultados: 41 pacientes entraron al estudio, se inyecto colágeno en 13, Macroplastique® en 14 y en 14 Deflux®. 29 pacientes recibieron inyección bilateral, resultando un total de 70 uréteres inyectados Con colágeno hubo 53% de éxito con la primera inyección y 77% con la segunda, con Macroplastique ® hubo 83% de éxito con la primera inyección y 91% con la segunda y con Deflux® 84% de éxito con la primera inyección Y 88% con la segunda inyección. El seguimiento post operatorio fue en promedio de 44 meses, con un rango de 18 a 86 meses. 18% presentó ITU post operatoria la que sé presento en pacientes con falla en el tratamiento. En el seguimiento no hay episodios de ITU en los pacientes con éxito en la aplicación de la sustancia. Conclusiones: El tratamiento endoscopio es una herramienta útil en el manejo del RVU a largo plazo, ya sea como tratamiento definitivo o como alternativa al manejo médico convencional, obteniendo mayor respuesta con Macroplastique® y Deflux® (AU)

Objectives: The VUR is one of the most frequent pathologies in pediatric urology. Classically it has been managed with medical or surgical treatment depending on age, grade, and other variables. Over the last years, urologists have started to perform endoscopic treatment with various substances, surgery but minimally invasive. The objective of this work is to evaluate our results with this method. Methods: Between 1996 and 2004 we performed endoscopic treatment on 41 patients (70 ureters) using different substances. We analyze VUR grade and side, improvement with one or more injections, post-operative follow-up with clinical evaluation, bladder ultrasound and voiding cystourethrogram (VCUG), and compare the long-term results of the different substances used, mainly with the evaluation of recurrences and/or urinary tract infections. Results: 41 patients entered the study; collagen was injected in 13 cases, Macroplastique® in 14, and Deflux® in 14. Twenty-nine patients underwent bilateral injection, adding up to a total of 70 injected ureters. Collagen injection had a success rate of 53% with the first injection and 77% with the second, Macroplastique® success rate was 83% with the first injection and 91% with the second, and Deflux® 84% on first injection and 88% with the second. Mean post-operative follow-up was 44 months, with a range of 18-86 months. 18% of the patients presented post operative UTI, they were treatment failures. There are no UTI episodes in patients after successful treatment. Conclusions: Endoscopic treatment is a useful tool in the long-term management of VUR, both as definitive treatment or as an alternative to conventional medical management, with better results when using Macroplastique® and Deflux® (AU)